
Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting
Hematologic Oncology Update
00:00
Navita Clocks and Bone Marrow Fibrosis
navita clocks two rucksolitinib in people who are terra pinaiv. 35% volumetric reduction in spleen there was some improvement in the symptoms as well one issue with this drug navita clocks is which is vcl2 and vclxinibitinib it's not that simple. early intervention with the best combination so one approach is here to add navita clocks to a face three study underway.
Transcript
Play full episode